{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T22:46:01Z","timestamp":1776811561626,"version":"3.51.2"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003125","name":"Suomen Kulttuurirahasto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011797","name":"Turun Yliopistollinen Keskussairaala","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jns.2019.116520","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T19:17:35Z","timestamp":1571339855000},"page":"116520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Hospital admission and prevalence trends of adult myasthenia gravis in Finland in 2004\u20132014: A retrospective national registry study"],"prefix":"10.1016","volume":"407","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0183-9054","authenticated-orcid":false,"given":"Jussi O.T.","family":"Sipil\u00e4","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merja","family":"Soilu-H\u00e4nninen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e4ivi","family":"Rautava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ville","family":"Kyt\u00f6","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2019.116520_bb0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/cei.12258","article-title":"Management of disease-modifying treatments in neurological autoimmune diseases of the central nervous system","volume":"176","author":"Salmen","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jns.2019.116520_bb0010","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1517\/14656566.2012.705831","article-title":"Treatment strategies for myasthenia gravis: an update","volume":"13","author":"D\u00edaz-Manera","year":"2012","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.jns.2019.116520_bb0015","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00415-018-8751-9","article-title":"Myasthenia gravis and infectious disease","volume":"265","author":"Gilhus","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2019.116520_bb0020","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/ene.12703","article-title":"Myasthenia gravis: descriptive analysis of life-threatening events in a recent nationwide registry","volume":"22","author":"Ramos-Fransi","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2019.116520_bb0025","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2019.116520_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/1756285608093888","article-title":"Review: progress in the treatment of myasthenia gravis","volume":"1","author":"Gold","year":"2008","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jns.2019.116520_bb0035","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1468-1331.2010.03019.x","article-title":"Guidelines for treatment of autoimmune neuromuscular transmission disorders","volume":"17","author":"Skeie","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2019.116520_bb0040","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/07853890.2018.1461919","article-title":"Adult hospital admissions associated with multiple sclerosis in Finland in 2004-2014","volume":"50","author":"Pirttisalo","year":"2018","journal-title":"Ann. Med."},{"key":"10.1016\/j.jns.2019.116520_bb0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/jnnp.74.1.25","article-title":"Increasing incidence in relapsing-remitting MS and high rates among young women in Finland: a thirty-year follow-up","volume":"74","author":"Sumelahti","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.116520_bb0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1352458510384012","article-title":"Increasing incidence of multiple sclerosis in women in northern Finland","volume":"17","author":"Kr\u00f6kki","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2019.116520_bb0055","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/ane.12623","article-title":"Risk of osteoporotic fractures in multiple sclerosis patients in Southwest Finland","volume":"135","author":"\u00c5ivo","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2019.116520_bb0060","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/ane.13057","article-title":"Multiple sclerosis epidemiology in Finland: longitudinal gradient and high incidence","volume":"139","author":"Pirttisalo","year":"2019","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2019.116520_bb0065","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/mus.25624","article-title":"Inpatient cost analysis for treatment of myasthenia gravis","volume":"56","author":"Omorodion","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2019.116520_bb0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000487886","article-title":"Epidemiology of myasthenia gravis in Slovakia in the years 1977-2015","volume":"50","author":"Martinka","year":"2018","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jns.2019.116520_bb0075","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/mus.25068","article-title":"Epidemiology of myasthenia gravis in northern Portugal: frequency estimates and clinical epidemiological distribution of cases","volume":"54","author":"Santos","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2019.116520_bb0080","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00508-012-0258-2","article-title":"Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society","volume":"124","author":"Cetin","year":"2012","journal-title":"Wien. Klin. Wochenschr."},{"issue":"Suppl","key":"10.1016\/j.jns.2019.116520_bb0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/ane.12233","article-title":"Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries","volume":"198","author":"Andersen","year":"2014","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2019.116520_bb0090","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in myasthenia gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jns.2019.116520_bb0095","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0022-510X(69)90090-2","article-title":"Epidemiology of myasthenia gravis in Finland","volume":"9","author":"Hokkanen","year":"1969","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.116520_bb0100","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-0404.1977.tb01445.x","article-title":"Genetic aspects in myasthenia gravis. A family study of 264 Finnish patients","volume":"56","author":"Pirskanen","year":"1977","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2019.116520_bb0105","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/ene.13535","article-title":"A nationwide epidemiological study of myasthenia gravis in Latvia","volume":"25","author":"Zieda","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2019.116520_bb0110","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000328863","article-title":"Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years","volume":"36","author":"Pallaver","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jns.2019.116520_bb0115","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0140-6736(08)60765-5","article-title":"Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study","volume":"371","author":"Harjutsalo","year":"2008","journal-title":"Lancet."},{"issue":"Suppl. 3","key":"10.1016\/j.jns.2019.116520_bb0120","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1186\/ar578","article-title":"Epidemiology and genetics of rheumatoid arthritis","volume":"4","author":"Silman","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.jns.2019.116520_bb0125","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000336002","article-title":"Epidemiology and geographical variation of myasthenia gravis in the province of Pavia, Italy","volume":"38","author":"Montomoli","year":"2012","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jns.2019.116520_bb0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nmd.2015.10.009","article-title":"Epidemiology of myasthenia gravis in Ontario, Canada","volume":"26","author":"Breiner","year":"2016","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2019.116520_bb0135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2019.116520_bb0140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrneurol.2016.188","article-title":"Treatment decisions in multiple sclerosis - insights from real-world observational studies","volume":"13","author":"Trojano","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2019.116520_bb0145","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2018.4905","article-title":"Clinical outcomes of escalation vs early intensive disease-modifying therapy in patients with multiple sclerosis","author":"Harding","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2019.116520_bb0150","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/ene.13692","article-title":"Early versus later treatment start in multiple sclerosis: a register-based cohort study","volume":"25","author":"Chalmer","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2019.116520_bb0155","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2019.116520_bb0160","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/1403494812456637","article-title":"Quality of the Finnish hospital discharge register: a systematic review","volume":"40","author":"Sund","year":"2012","journal-title":"Scand. J. Public Health"},{"key":"10.1016\/j.jns.2019.116520_bb0165","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000184748","article-title":"The epidemiology of Guillain-Barr\u00e9 syndrome worldwide","volume":"32","author":"McGrogan","year":"2009","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jns.2019.116520_bb0170","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/07853890.2016.1254350","article-title":"Seasonality of stroke in Finland","volume":"49","author":"Sipil\u00e4","year":"2017","journal-title":"Ann. Med."},{"key":"10.1016\/j.jns.2019.116520_bb0175","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/jns.12239","article-title":"Epidemiology of Guillain-Barr\u00e9 syndrome in Finland 2004-2014","volume":"22","author":"Sipil\u00e4","year":"2017","journal-title":"J. Peripher. Nerv. Syst."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19304526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19304526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:48:04Z","timestamp":1758383284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X19304526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":35,"alternative-id":["S0022510X19304526"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2019.116520","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hospital admission and prevalence trends of adult myasthenia gravis in Finland in 2004\u20132014: A retrospective national registry study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2019.116520","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116520"}}